Clinical Trial Update: Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy [Phase 2]

View source ↗

Summary

This update concerns a long-term extension study of DS-5141b in Duchenne muscular dystrophy; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• DS-5141b

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Duchenne Muscular Dystrophy | Phase 2 | Status: ACTIVE_NOT_RECRUITING